- GALT Dashboard
- Financials
- Filings
-
Holdings
-
Transcripts
- ETFs
- Insider
- Institutional
- Shorts
-
S-3 Filing
Galectin Therapeutics (GALT) S-3Shelf registration
Filed: 16 Mar 11, 12:00am
Exhibit 23.3
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We consent to the incorporation by reference in this Registration Statement on Form S-3 of our report dated March 12, 2010, relating to our audit of the consolidated financial statements of Pro-Pharmaceuticals, Inc. as of and for the year ended December 31, 2009 (which report expresses an unqualified opinion and includes an explanatory paragraph relating to the substantial doubt about the Company’s ability to continue as a going concern as discussed in Note 1), appearing in the Annual Report on Form 10-K of Pro-Pharmaceuticals, Inc. for the year ended December 31, 2010, and to the reference to us under the heading “Experts” in the Prospectus, which is part of this Registration Statement.
/s/ Caturano and Company, Inc.
Boston, Massachusetts
March 15, 2011